Rapport Therapeutics (RAPP) Income Statement (2023 - 2026)
Income Statement report data from Mar 31, 2023 to Mar 31, 2026 for Rapport Therapeutics (RAPP).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||
Total Revenue | 20M | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses | |||||||||||||
Research And Development | 33M (+8.13%) | 30M (+35.82%) | 22M (-1.76%) | 23M (+15.89%) | 20M (+13.78%) | 17M (+10.68%) | 16M (-0.96%) | 16M (+25.52%) | 13M (-20.38%) | 16M (+107.12%) | 7.58M (+60.59%) | 4.72M | - |
Selling General And Administrative | 12M (+39.39%) | 8.25M (+7.00%) | 7.71M (+13.05%) | 6.82M (-9.55%) | 7.54M (+19.30%) | 6.32M (+3.61%) | 6.10M (+19.37%) | 5.11M (+11.33%) | 4.59M (+6.99%) | 4.29M (+116.67%) | 1.98M (+3.66%) | 1.91M | - |
Operating Expenses | 44M (+14.83%) | 39M (+28.41%) | 30M (+1.66%) | 30M (+8.82%) | 27M (+15.26%) | 24M (+8.69%) | 22M (+4.04%) | 21M (+21.71%) | 17M (-14.51%) | 20M (+109.10%) | 9.56M (+44.19%) | 6.63M | - |
Depreciation And Amortization | 230K (-70.13%) | 770K | - | - | 240K (-17.24%) | 290K (+45.00%) | 200K (0.00%) | 200K (+33.33%) | 150K (+36.36%) | 110K | - | - | - |
Operating Income | |||||||||||||
Operating Income | -24.21M (-37.13%) | -38.51M (+28.41%) | -29.99M (+1.66%) | -29.50M (+8.82%) | -27.11M (+15.26%) | -23.52M (+8.69%) | -21.64M (+4.04%) | -20.80M (+21.71%) | -17.09M (-14.46%) | -19.98M (+109.00%) | -9.56M (+44.19%) | -6.63M | - |
Ebit | -24.21M (-37.13%) | -38.51M (+28.41%) | -29.99M (+1.66%) | -29.50M (+8.82%) | -27.11M (+15.26%) | -23.52M (+8.69%) | -21.64M (+4.04%) | -20.80M (+21.71%) | -17.09M (+23.48%) | -13.84M (+44.77%) | -9.56M (+44.19%) | -6.63M (+7.80%) | -6.15M |
EBITDA | -23.99M (-44.93%) | -43.56M (+61.81%) | -26.92M (+0.71%) | -26.73M (-0.48%) | -26.86M (+15.63%) | -23.23M (+8.35%) | -21.44M (+4.08%) | -20.60M (+21.61%) | -16.94M (+14.46%) | -14.80M (+69.92%) | -8.71M (+35.88%) | -6.41M (+4.23%) | -6.15M |
Other Income / Expenses | |||||||||||||
Interest Income | 4.36M (-8.21%) | 4.75M (+55.23%) | 3.06M (+10.87%) | 2.76M (-9.51%) | 3.05M (-13.84%) | 3.54M (-13.66%) | 4.10M (+52.99%) | 2.68M (+47.25%) | 1.82M (+25.52%) | 1.45M (+68.60%) | 860K (+290.91%) | 220K | - |
Net Interest Income | 4.36M (-8.21%) | 4.75M (+55.23%) | 3.06M (+10.87%) | 2.76M (-9.51%) | 3.05M (-13.84%) | 3.54M (-13.66%) | 4.10M (+52.99%) | 2.68M (+47.25%) | 1.82M (+25.52%) | 1.45M (+68.60%) | 860K (+290.91%) | 220K | - |
Other Non Operating Income | 4.36M (-67.99%) | 14M (+345.10%) | 3.06M (+10.87%) | 2.76M (-9.51%) | 3.05M (-35.79%) | 4.75M (+15.85%) | 4.10M (+52.99%) | 2.68M | -5.57M | 1.40M (+62.79%) | 860K (+290.91%) | 220K | - |
Net Income | |||||||||||||
Income Before Tax | - | - | - | - | - | -42.65M (+143.16%) | -17.54M (-3.20%) | -18.12M | - | -19.66M (+125.72%) | -8.71M (+35.88%) | -6.41M | - |
Income Tax Expense | - | - | - | - | - | - | - | - | - | 10K | - | - | - |
Net Income From Continuing Operations | -19.86M (-41.17%) | -33.76M (+25.41%) | -26.92M (+0.71%) | -26.73M (+11.10%) | -24.06M (+20.42%) | -19.98M (+13.91%) | -17.54M (-3.20%) | -18.12M (-20.07%) | -22.67M (+67.68%) | -13.52M (+55.22%) | -8.71M (+35.88%) | -6.41M (+4.23%) | -6.15M |
Net Income | -19.86M (-41.17%) | -33.76M (+25.41%) | -26.92M (+0.71%) | -26.73M (+11.10%) | -24.06M (+20.42%) | -19.98M (+13.91%) | -17.54M (-3.20%) | -18.12M (-20.07%) | -22.67M (+67.68%) | -13.52M (+55.22%) | -8.71M (+35.88%) | -6.41M (+4.23%) | -6.15M |
Comprehensive Income Net Of Tax | -20.91M (-81.06%) | -110.41M (+313.52%) | -26.70M (-0.04%) | -26.71M (+12.99%) | -23.64M (-70.01%) | -78.83M (+365.07%) | -16.95M (-6.56%) | -18.14M (-20.54%) | -22.83M (-34.36%) | -34.78M (+299.31%) | -8.71M (+35.88%) | -6.41M | - |